Ocumension Therapeutics Financial Overview
Ocumension Therapeutics's market cap is currently HK$6.60B. The company's EPS TTM is HK$-0.18571400440000002; its P/E ratio is -22.83; Ocumension Therapeutics is scheduled to report earnings on August 21, 2025, and the estimated EPS forecast is HK$-0.03. See an overview of income statement, balance sheet, and cash flow financials.
